Twenty years' single-center experience with mechanical heart valves: A critical review of anticoagulation policy

Journal of Heart Valve Disease

Volumn 21, Issue 1, 2012, Pages 88-98

  Van Nooten, Guido J ^a   Caes, Frank ^a   François, Katrien ^a   Van Bellleghem, Yves ^a   Bové, Thierry ^a   Vandenplas, Guy ^a   Taeymans, Yves ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL BLEEDING; ADULT; AGED; ANTICOAGULANT THERAPY; ANTICOAGULATION; AORTA STENOSIS; AORTA VALVE REGURGITATION; AORTA VALVE REPLACEMENT; ARTICLE; ATS VALVE; BLEEDING; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CARDIOMYOPATHY; CARDIOPULMONARY BYPASS; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY FAILURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEART ATRIUM FIBRILLATION; HEART DEATH; HEART FAILURE; HEART TRANSPLANTATION; HEART VALVE PROSTHESIS; HEMODIALYSIS; HEMOLYSIS; HUMAN; HYPERTENSION; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE; MITRAL VALVE PROSTHESIS; MITRAL VALVE REPAIR; MITRAL VALVE REPLACEMENT; MORTALITY; MULTIPLE ORGAN FAILURE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSTHETIC VALVE ENDOCARDITIS; PROSTHETIC VALVE THROMBOSIS; PULMONARY VALVE REPLACEMENT; REOPERATION; RHEUMATIC HEART DISEASE; SINUS RHYTHM; SUDDEN DEATH; THROMBOEMBOLISM; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME; TRICUSPID VALVE REPAIR; TRICUSPID VALVE REPLACEMENT; VALVE; BELGIUM; BLOOD CLOTTING; CAUSE OF DEATH; DRUG EFFECT; DRUG MONITORING; HEART VALVE REPLACEMENT; KAPLAN MEIER METHOD; MANAGEMENT; METHODOLOGY; MIDDLE AGED; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK FACTOR; STANDARD; STATISTICS;

ANTICOAGULANT AGENT; WARFARIN;

AGED; ANTICOAGULANTS; BELGIUM; BLOOD COAGULATION; CAUSE OF DEATH; DRUG MONITORING; FEMALE; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HEMORRHAGE; HUMANS; INTERNATIONAL NORMALIZED RATIO; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); POLICY MAKING; POSTOPERATIVE COMPLICATIONS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; THROMBOEMBOLISM; WARFARIN;

EID: 84860319908     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Van Nooten G, Caes F, François K, Missault L, Van Belleghem Y. Clinical experience with the first 100 ATS Heart valve implants. Cardiovasc Surg 1996;4:288-292
2. Akins CW, Miller DC, Turina MI, et al. AATS and EACTS Guidelines for reporting mortality and morbidity after cardiac valve interventions. Ann Thorac Surg 2008;85:1490-1405
3. Emery RW, Krogh CC, Arom KV, et al. The St. Jude Medical cardiac valve prosthesis: A 25-year experience with single valve replacement. Ann Thorac Surg 2005;79:776-782; discussion 782-783
4. Lund O, Nielsen SL, Arildsen H, Ilkjaer LB, Pilegaard HK. Standard aortic St. Jude valve at 18 years: Performance profile and determinants of outcome. Ann Thorac Surg 2000;69:1459-1465
5. Bernet FH, Baykut D, Grize L, Zerkowski HR. Single-center outcome analysis of 1,161 patients with St. Jude Medical and ATS open pivot mechanical heart valves. J Heart Valve Dis 2007;12:151-158
6. Emery R, Van Nooten GJ, Tesar PJ. The initial experience with the ATS Medical mechanical cardiac valve prosthesis. Ann Thorac Surg 2003;75:444-452
7. Bryan AJ, Rogers CA, Bayliss K, Wild J, Angelini GD. Prospective randomized comparison of CarboMedics and St. Jude Medical bileaflet mechanical heart valve prostheses: Ten-year follow-up. J Thorac Cardiovasc Surg 2007;133:614-622
8. Aagaard J, Tingleff J. Fifteen years' clinical experience with the CarboMedics prosthetic heart valve. J Heart Valve Dis 2005;14:82-88
9. Edwards E, Peterson E, Coombs L, et al. Prediction of operative mortality after valve replacement surgery. J Am Coll Cardiol 2001;37:885-892
10. Brown J, O'Brien S, Wu C, Sikora J, Griffith B, Gammie J. Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: Changes in risks, valve types and outcome in the STS national database. J Thorac Cardiovasc Surg 2009;137:82-90
11. http://www.nationmaster.com/graph/hea-life-expectancy-birth-years
12. Teoh KH, Ivanov J, Weisel RD. Determinants of survival and valve failure after mitral valve replacement. Ann Thorac Surg 1990;49:643-648
13. De Feo M, Onorati F, Renzulli A, et al. Mechanical prosthesis is still a valid option for aortic valve replacement in the elderly. J Heart Valve Dis 2004;13:103-108
14. Accola KD, Scott ML, Palmer GJ, et al. Surgical management of aortic valve disease in the elderly: A retrospective comparative study of valve choice using propensity score analysis. J Heart Valve Dis 2008;17:355-364; discussion 365
15. de Vincentis C, Kunkl AB, Trimarchi S, et al. Aortic valve replacement in octogenarians: Is biologic valve the unique solution? Ann Thorac Surg 2008;85:1296-1301
16. Ruel M, Kulik A, Lam BK, et al. Long-term outcomes of valve replacement with modern prostheses in young adults. Eur J Cardiothorac Surg 2005;27:425-433; discussion 433
17. Del Rizzo DF, Freed D, Abdoh A, et al. Midterm survival of stented versus stentless valves: Does concomitant coronary artery bypass grafting impact survival? Semin Thorac Cardiovasc Surg 2001;13:148-155
18. Dürrleman N, Pellerin M, Bouchard D, et al. Prosthetic valve thrombosis: Twenty-year experience at the Montreal Heart Institute. J Thorac Cardiovasc Surg 2004;127:1388-1392
19. Kuntze C, Ebels T, Eijgelaer A, Homan Van Der Heide JN. Rates of thromboembolism with three different mechanical heart valve prosthesis; randomised study. Lancet 1989;11:514-517
20. Emery RW, Emery AM, Raikar GV, Shake JG. Anticoagulation for mechanical heart valves: A role for patient-based therapy. J Thromb Thrombolysis 2008;25:18-25
21. Albers GW. Warfarin prevails for stroke prevention in atrial fibrillation even in octogenarians. Lancet Neurol 2007;6:844-846
22. Graham SP. To anticoagulate or not to anticoagulate patients with cardiomyopathy. Cardiol Clin 2001;19:605-615
23. Romualdi E, Micieli E, Ageno W, Squizzato A. Oral anticoagulant therapy in patients with mechanical valve and intracranial bleeding. A systematic review. Thromb Haemost 2009;101:290-297
24. Hammermeister K, Sethi G, Henderson W, Grover F, Oprian C, Rahmintoola S. Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: Final report on the Veterans Affairs Randomized Trial. J Am Coll Cardiol 2000;4:1152-1158
25. Hering D, Piper C, Bergemann R, et al. Thromboembolic and bleeding complications following St. Jude Medical valve replacement: Results of the German Experience With Low-Intensity Anticoagulation Study. Chest 2005;127:53-59
26. Massel D, Little SH. Risks and benefits of adding anti-platelet therapy to warfarin among patients with prosthetic heart valves: A meta-analysis. J Am Coll Cardiol 2001;37:569-578
27. Meschengieter SS, Fondevila CG, Frontroth J, et al. Low-intensity oral anticoagulation plus low dose aspirin versus high-intensity oral anticoagulation alone: A randomized trial in patients with mechanical prosthetic heart valves. J Thorac Cardiovasc Surg 1997;113:910-916
28. Arom KV, Emery RW, Nicoloff DM, Petersen RJ. Anticoagulant-related complications in elderly patients with St. Jude mechanical valve prostheses. J Heart Valve Dis 1996;5:505-510
29. Van Nooten GJ, Van Belleghem Y, Caes F, et al. Lower-intensity anticoagulation for mechanical heart valves: A new concept with the ATS bileaflet aortic valve. J Heart Valve Dis 2003;12:495-501; discussion 502
30. Acar J, Lung B, Boissel JP, et al. AREVA; multicenter randomized comparison of low-dose versus standard dose anticoagulation in patients with mechanical prosthetic heart valves. Circulation 1996;94:2107-2112
31. Koertke H, Zittermann A, Tenderich G, et al. Low-dose oral anticoagulation in patients with mechanical heart valve prostheses: Final report from the early self-management anticoagulation trial II. Eur Heart J 2007;28:2479-2484
32. Bodnar E, Horstkotte D. Potential flaws in the assessment of minor cerebro-vascular events after heart valve replacement. J Heart Valve Dis 1993;2:287-290